RA Capital Healthcare Fund LP files SEC Form 4 disclosures for SANGAMO BIOSCIENCES INC. They have made 41 open-market trades across 21 companies since 2013, most recently 2026-02-19.
30 open-market purchases totalling $389.6M since 2013, against 11 sales. Across 30 scored buys the stock is up 5.7% at ninety days, and 3.0 points ahead of the S&P over the same stretch.
30 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 37% | 57% |
| Avg Move | -1.2% | +0.5% | +5.7% |
| Alpha | -0.5% | +0.8% | +3.0% |
| Scored | 30 | 30 | 30 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 91% | 64% | 55% |
| Avg Move | -20.6% | -5.3% | -7.8% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGP | BUY | 2026-02-09 | 2026-02-11 | $16.00 | $59.0M | +4.8% | -5.0% | -13.7% |
| CLYM | BUY | 2026-01-05 | 2026-01-07 | $3.50 | $25K | +0.7% | +26.8% | +59.8% |
| FULC | SELL | 2025-12-08 | 2025-12-10 | $13.98 | $116.8M | -5.7% | -27.3% | -40.9% |
| PEPG | BUY | 2025-09-26 | 2025-09-30 | $3.20 | $30.0M | -7.5% | -11.2% | +19.8% |
| TYRA | BUY | 2025-06-09 | 2025-06-11 | $10.19 | $3.8M | -5.6% | -0.6% | +14.5% |
| JANX | BUY | 2025-03-05 | 2025-03-07 | $30.75 | $50.7M | -1.1% | -22.0% | -20.8% |
| TYRA | BUY | 2024-11-08 | 2024-11-13 | $16.25 | $39.7M | -2.5% | -9.9% | -26.9% |
| ANTX | SELL | 2024-08-09 | 2024-08-13 | $1.08 | $7.6M | +2.8% | -2.8% | +1.9% |
| SPRY | BUY | 2023-09-21 | 2023-09-25 | $3.03 | $16.4M | +3.1% | -10.1% | +42.9% |
| FULC | BUY | 2023-01-04 | 2023-01-06 | $7.28 | $2.6M | +24.1% | +26.8% | -75.7% |
| ACRV | BUY | 2022-11-17 | 2022-11-21 | $12.50 | $42.4M | -5.2% | -10.7% | +37.2% |
| WVE | BUY | 2022-06-16 | 2022-06-21 | $2.15 | $40.8M | +45.2% | +70.8% | +54.8% |
| ICVX | BUY | 2022-03-28 | 2022-03-30 | $4.54 | $1.6M | +54.7% | +26.7% | +47.2% |
| CTKB | BUY | 2022-03-14 | 2022-03-16 | $12.32 | $14.4M | -20.9% | -16.8% | -23.9% |
| HOWL | BUY | 2021-06-14 | 2021-06-16 | $12.77 | $8.3M | +7.5% | +9.3% | +17.9% |
| ETNB | BUY | 2021-06-02 | 2021-06-04 | $18.77 | $831K | +5.5% | -9.8% | +3.1% |
| ETNB | BUY | 2021-05-26 | 2021-05-28 | $18.60 | $7.7M | +0.4% | -0.2% | -3.4% |
| SCPH | SELL | 2021-03-12 | 2021-03-16 | $7.08 | $2.1M | -5.4% | -4.7% | -17.9% |
| ORTX | BUY | 2020-08-10 | 2020-11-06 | $4.63 | $6.9M | -11.8% | -5.5% | +26.9% |
| VSTM | SELL | 2020-06-25 | 2020-06-29 | $1.91 | $2.2M | -14.2% | -19.2% | -24.9% |
| PHAT | BUY | 2020-04-01 | 2020-04-03 | $24.86 | $2.9M | -8.9% | -2.7% | -0.1% |
| SCPH | BUY | 2020-02-14 | 2020-02-21 | $8.20 | $2.2M | -4.9% | -46.4% | -19.2% |
| ETNB | BUY | 2019-11-11 | 2019-11-13 | $16.00 | $24.0M | +47.8% | +52.7% | +37.8% |
| SCPH | BUY | 2019-04-11 | 2019-04-15 | $2.70 | $2.1M | +42.6% | +33.8% | +42.2% |
| ACRS | BUY | 2016-02-22 | 2016-02-24 | $17.16 | $1.4M | -4.8% | -20.8% | +5.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CTKB | 13,139,327 | $69.1M |
| BSTC | 752,746 | $66.6M |
| PEPG | 18,554,273 | $47.9M |
| SGP | 1,806,644 | $43.6M |
| ACHN | 5,185,457 | $35.1M |
| SPRY | 8,365,465 | $33.5M |
| CLYM | 3,403,429 | $33.4M |
| ITOS | 3,155,667 | $32.0M |
| RARX | 616,646 | $29.6M |
| PHAT | 3,825,008 | $26.5M |
| FULC | 6,145,682 | $22.5M |
| ETNB | 1,081,081 | $16.0M |
| SCPH | 2,727,446 | $15.5M |
| EVMN | 2,710,293 | $14.0M |
| ACRV | 7,914,206 | $13.0M |
| ACRS | 2,627,719 | $8.6M |
| ANTX | 1,725,348 | $5.8M |
| SLDB | 787,586 | $4.4M |
| HOWL | 4,291,881 | $4.2M |
| SGMO | 3,526,662 | $624K |
| MLYS | 6,200 | $126K |
| JANX | 6,250 | $103K |
| WVE | 28,815 | $90K |
| KALA | 279,846 | $52K |
| ABOS | 12,800 | $22K |
| Total | $2.4B |
Shares reported on the most recent Form 4, priced at the 2026-02-20 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 11 | 11 | 11 |